Rosa Isela Sánchez-Nájera Selected Research

bismuth dimercaptopropanol (BisBal)

1/2022	Bismuth Lipophilic Nanoparticles (BisBAL NP) Inhibit the Growth of Tumor Cells in a Mouse Melanoma Model.
1/2018	In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosa Isela Sánchez-Nájera Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 01/2018
1	Melanoma (Melanoma, Malignant) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

2	bismuth dimercaptopropanol (BisBal)IBA 01/2022 - 01/2018
2	BismuthIBA 01/2022 - 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018